GlaxoSmithKline and Merck KGaA announced a joint decision to terminate their global collaboration on bintrafusp alfa, effective September 30, 2021. Bintrafusp alfa is an investigational bifunctional fusion protein…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.